Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
- A8365 Varlitinib (ARRY334543)Summary: ErbB inhibitor
- A8366 ARRY-380Target: HER2Summary: Tyrosine kinase HER2 and p95-HER2 inhibitor
- A8367 AST-1306Summary: EGFR/HER2 inhibitor
- A8370 Axitinib (AG 013736)1 CitationTarget: VEGFR|PDGFR|c-KitSummary: VEGFR1/ c-Kit inhibitor
- A8375 AZD8931 (Sapitinib)Target: EGFR|ErbBSummary: ErbB inhibitor
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: IGF-IR/IR/ALK inhibitor, ATP-competitive
- A8448 INCB28060Target: c-METSummary: C-Met inhibitor,ATP-competitive and novel
- A8476 MK-2461Target: FLT3|PDGFR|MET|RonSummary: C-Met (WT/mutants) inhibitor
- A8489 NVP-BVU972Summary: C-Met inhibitor,potent and selective
- A8528 TAK-285Target: EGFR|HER2Summary: HER2/EGFR(HER1) inhibitor